# [CD83]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |2   |
|DLBCL |1   |
|FL    |1   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture|1.15         |
|BL    |Thomas cohort        |1.70         |
|BL    |Panea cohort         |  NA         |
|DLBCL |GAMBL genomes        |4.50         |
|DLBCL |Schmitz cohort       |5.70         |
|DLBCL |Reddy cohort         |5.80         |
|DLBCL |Chapuy cohort        |7.30         |
|FL    |GAMBL genomes        |1.85         |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |Yes |No                   |4.396           | 0.000          |
|DLBCL |Yes |No                   |4.794           |14.227          |
|FL    |Yes |No                   |0.000           |25.732          |

## aSHM regions

|chr_name|hg19_start|hg19_end|region|regulatory_comment             |
|--------|----------|--------|------|-------------------------------|
|chr6    |14118026  |14120025|TSS   |active_promoter-strong_enhancer|

> [!NOTE]
> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468). First described in DLBCL in 2018 by [Schmitz R](https://pubmed.ncbi.nlm.nih.gov/29641966). First described in FL in 2023 by [Russler-Germain DA](https://pubmed.ncbi.nlm.nih.gov/37493986)